Overall, these results suggest that methylation of the 5 ́ region of ZNF677 is responsible for ZNF677 silencing in many tumor cell lines of different entities including NSCLC, breast cancer, colon cancer, ovarian cancer, pancreatic cancer and head and neck cancer. Here, ZNF677 is linked to malignant colon neoplasm.